Cover Image
Market Research Report
Product code 
1052497

Global Metabolomics Market Insights and Forecast to 2028

Published: | QYResearch | 114 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Metabolomics Market Insights and Forecast to 2028
Published: January 18, 2022
QYResearch
Content info: 114 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Market Analysis and Insights: Global Metabolomics Market

The global Metabolomics market size is projected to reach US$ 3061 million by 2028, from US$ 1422.7 million in 2021, at a CAGR of 11.1% during 2022-2028.

Fully considering the economic change by this health crisis, Separation Techniques accounting for % of the Metabolomics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Drug Assessment segment is altered to an % CAGR throughout this forecast period.

China Metabolomics market size is valued at US$ million in 2021, while the North America and Europe Metabolomics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Metabolomics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolomics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolomics market.

Global Metabolomics Scope and Market Size

Metabolomics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metabolomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Separation Techniques
  • Detection Techniques
  • Others

Segment by Application

  • Drug Assessment
  • Biomarker Discovery
  • Nutrigenomics
  • Clinical toxicology
  • Others

By Company

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Shimadzu Corporation
  • Waters Corporation
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Metabolomics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Separation Techniques
    • 1.2.3 Detection Techniques
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Metabolomics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Drug Assessment
    • 1.3.3 Biomarker Discovery
    • 1.3.4 Nutrigenomics
    • 1.3.5 Clinical toxicology
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Metabolomics Market Perspective (2017-2028)
  • 2.2 Metabolomics Growth Trends by Region
    • 2.2.1 Metabolomics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Metabolomics Historic Market Size by Region (2017-2022)
    • 2.2.3 Metabolomics Forecasted Market Size by Region (2023-2028)
  • 2.3 Metabolomics Market Dynamics
    • 2.3.1 Metabolomics Industry Trends
    • 2.3.2 Metabolomics Market Drivers
    • 2.3.3 Metabolomics Market Challenges
    • 2.3.4 Metabolomics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Metabolomics Players by Revenue
    • 3.1.1 Global Top Metabolomics Players by Revenue (2017-2022)
    • 3.1.2 Global Metabolomics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Metabolomics Revenue
  • 3.4 Global Metabolomics Market Concentration Ratio
    • 3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2021
  • 3.5 Metabolomics Key Players Head office and Area Served
  • 3.6 Key Players Metabolomics Product Solution and Service
  • 3.7 Date of Enter into Metabolomics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolomics Breakdown Data by Type

  • 4.1 Global Metabolomics Historic Market Size by Type (2017-2022)
  • 4.2 Global Metabolomics Forecasted Market Size by Type (2023-2028)

5 Metabolomics Breakdown Data by Application

  • 5.1 Global Metabolomics Historic Market Size by Application (2017-2022)
  • 5.2 Global Metabolomics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Metabolomics Market Size (2017-2028)
  • 6.2 North America Metabolomics Market Size by Type
    • 6.2.1 North America Metabolomics Market Size by Type (2017-2022)
    • 6.2.2 North America Metabolomics Market Size by Type (2023-2028)
    • 6.2.3 North America Metabolomics Market Share by Type (2017-2028)
  • 6.3 North America Metabolomics Market Size by Application
    • 6.3.1 North America Metabolomics Market Size by Application (2017-2022)
    • 6.3.2 North America Metabolomics Market Size by Application (2023-2028)
    • 6.3.3 North America Metabolomics Market Share by Application (2017-2028)
  • 6.4 North America Metabolomics Market Size by Country
    • 6.4.1 North America Metabolomics Market Size by Country (2017-2022)
    • 6.4.2 North America Metabolomics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Metabolomics Market Size (2017-2028)
  • 7.2 Europe Metabolomics Market Size by Type
    • 7.2.1 Europe Metabolomics Market Size by Type (2017-2022)
    • 7.2.2 Europe Metabolomics Market Size by Type (2023-2028)
    • 7.2.3 Europe Metabolomics Market Share by Type (2017-2028)
  • 7.3 Europe Metabolomics Market Size by Application
    • 7.3.1 Europe Metabolomics Market Size by Application (2017-2022)
    • 7.3.2 Europe Metabolomics Market Size by Application (2023-2028)
    • 7.3.3 Europe Metabolomics Market Share by Application (2017-2028)
  • 7.4 Europe Metabolomics Market Size by Country
    • 7.4.1 Europe Metabolomics Market Size by Country (2017-2022)
    • 7.4.2 Europe Metabolomics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Metabolomics Market Size (2017-2028)
  • 8.2 Asia-Pacific Metabolomics Market Size by Type
    • 8.2.1 Asia-Pacific Metabolomics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Metabolomics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Metabolomics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Metabolomics Market Size by Application
    • 8.3.1 Asia-Pacific Metabolomics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Metabolomics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Metabolomics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Metabolomics Market Size by Region
    • 8.4.1 Asia-Pacific Metabolomics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Metabolomics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Metabolomics Market Size (2017-2028)
  • 9.2 Latin America Metabolomics Market Size by Type
    • 9.2.1 Latin America Metabolomics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Metabolomics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Metabolomics Market Share by Type (2017-2028)
  • 9.3 Latin America Metabolomics Market Size by Application
    • 9.3.1 Latin America Metabolomics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Metabolomics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Metabolomics Market Share by Application (2017-2028)
  • 9.4 Latin America Metabolomics Market Size by Country
    • 9.4.1 Latin America Metabolomics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Metabolomics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Metabolomics Market Size (2017-2028)
  • 10.2 Middle East & Africa Metabolomics Market Size by Type
    • 10.2.1 Middle East & Africa Metabolomics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Metabolomics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Metabolomics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Metabolomics Market Size by Application
    • 10.3.1 Middle East & Africa Metabolomics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Metabolomics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Metabolomics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Metabolomics Market Size by Country
    • 10.4.1 Middle East & Africa Metabolomics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Metabolomics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific, Inc.
    • 11.1.1 Thermo Fisher Scientific, Inc. Company Details
    • 11.1.2 Thermo Fisher Scientific, Inc. Business Overview
    • 11.1.3 Thermo Fisher Scientific, Inc. Metabolomics Introduction
    • 11.1.4 Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2017-2022)
    • 11.1.5 Thermo Fisher Scientific, Inc. Recent Developments
  • 11.2 Agilent Technologies, Inc.
    • 11.2.1 Agilent Technologies, Inc. Company Details
    • 11.2.2 Agilent Technologies, Inc. Business Overview
    • 11.2.3 Agilent Technologies, Inc. Metabolomics Introduction
    • 11.2.4 Agilent Technologies, Inc. Revenue in Metabolomics Business (2017-2022)
    • 11.2.5 Agilent Technologies, Inc. Recent Developments
  • 11.3 Biocrates Life Sciences AG
    • 11.3.1 Biocrates Life Sciences AG Company Details
    • 11.3.2 Biocrates Life Sciences AG Business Overview
    • 11.3.3 Biocrates Life Sciences AG Metabolomics Introduction
    • 11.3.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2017-2022)
    • 11.3.5 Biocrates Life Sciences AG Recent Developments
  • 11.4 Shimadzu Corporation
    • 11.4.1 Shimadzu Corporation Company Details
    • 11.4.2 Shimadzu Corporation Business Overview
    • 11.4.3 Shimadzu Corporation Metabolomics Introduction
    • 11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2017-2022)
    • 11.4.5 Shimadzu Corporation Recent Developments
  • 11.5 Waters Corporation
    • 11.5.1 Waters Corporation Company Details
    • 11.5.2 Waters Corporation Business Overview
    • 11.5.3 Waters Corporation Metabolomics Introduction
    • 11.5.4 Waters Corporation Revenue in Metabolomics Business (2017-2022)
    • 11.5.5 Waters Corporation Recent Developments
  • 11.6 Human Metabolome Technologies, Inc.
    • 11.6.1 Human Metabolome Technologies, Inc. Company Details
    • 11.6.2 Human Metabolome Technologies, Inc. Business Overview
    • 11.6.3 Human Metabolome Technologies, Inc. Metabolomics Introduction
    • 11.6.4 Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2017-2022)
    • 11.6.5 Human Metabolome Technologies, Inc. Recent Developments
  • 11.7 LECO Corporation
    • 11.7.1 LECO Corporation Company Details
    • 11.7.2 LECO Corporation Business Overview
    • 11.7.3 LECO Corporation Metabolomics Introduction
    • 11.7.4 LECO Corporation Revenue in Metabolomics Business (2017-2022)
    • 11.7.5 LECO Corporation Recent Developments
  • 11.8 Metabolon, Inc.
    • 11.8.1 Metabolon, Inc. Company Details
    • 11.8.2 Metabolon, Inc. Business Overview
    • 11.8.3 Metabolon, Inc. Metabolomics Introduction
    • 11.8.4 Metabolon, Inc. Revenue in Metabolomics Business (2017-2022)
    • 11.8.5 Metabolon, Inc. Recent Developments
  • 11.9 Bio-Rad Laboratories, Inc.
    • 11.9.1 Bio-Rad Laboratories, Inc. Company Details
    • 11.9.2 Bio-Rad Laboratories, Inc. Business Overview
    • 11.9.3 Bio-Rad Laboratories, Inc. Metabolomics Introduction
    • 11.9.4 Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2017-2022)
    • 11.9.5 Bio-Rad Laboratories, Inc. Recent Developments
  • 11.10 Bruker Corporation
    • 11.10.1 Bruker Corporation Company Details
    • 11.10.2 Bruker Corporation Business Overview
    • 11.10.3 Bruker Corporation Metabolomics Introduction
    • 11.10.4 Bruker Corporation Revenue in Metabolomics Business (2017-2022)
    • 11.10.5 Bruker Corporation Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Metabolomics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Separation Techniques
  • Table 3. Key Players of Detection Techniques
  • Table 4. Key Players of Others
  • Table 5. Global Metabolomics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Metabolomics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Metabolomics Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Metabolomics Market Share by Region (2017-2022)
  • Table 9. Global Metabolomics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Metabolomics Market Share by Region (2023-2028)
  • Table 11. Metabolomics Market Trends
  • Table 12. Metabolomics Market Drivers
  • Table 13. Metabolomics Market Challenges
  • Table 14. Metabolomics Market Restraints
  • Table 15. Global Metabolomics Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Metabolomics Revenue Share by Players (2017-2022)
  • Table 17. Global Top Metabolomics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics as of 2021)
  • Table 18. Ranking of Global Top Metabolomics Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Metabolomics Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Metabolomics Product Solution and Service
  • Table 22. Date of Enter into Metabolomics Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Metabolomics Revenue Market Share by Type (2017-2022)
  • Table 26. Global Metabolomics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Metabolomics Revenue Market Share by Type (2023-2028)
  • Table 28. Global Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Metabolomics Revenue Share by Application (2017-2022)
  • Table 30. Global Metabolomics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Metabolomics Revenue Share by Application (2023-2028)
  • Table 32. North America Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Metabolomics Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Metabolomics Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Metabolomics Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Metabolomics Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Metabolomics Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Metabolomics Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Metabolomics Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Metabolomics Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Metabolomics Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Metabolomics Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Metabolomics Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Metabolomics Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Metabolomics Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Metabolomics Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Metabolomics Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Metabolomics Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Metabolomics Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Metabolomics Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Metabolomics Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Metabolomics Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Metabolomics Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Metabolomics Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Thermo Fisher Scientific, Inc. Company Details
  • Table 63. Thermo Fisher Scientific, Inc. Business Overview
  • Table 64. Thermo Fisher Scientific, Inc. Metabolomics Product
  • Table 65. Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 66. Thermo Fisher Scientific, Inc. Recent Developments
  • Table 67. Agilent Technologies, Inc. Company Details
  • Table 68. Agilent Technologies, Inc. Business Overview
  • Table 69. Agilent Technologies, Inc. Metabolomics Product
  • Table 70. Agilent Technologies, Inc. Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 71. Agilent Technologies, Inc. Recent Developments
  • Table 72. Biocrates Life Sciences AG Company Details
  • Table 73. Biocrates Life Sciences AG Business Overview
  • Table 74. Biocrates Life Sciences AG Metabolomics Product
  • Table 75. Biocrates Life Sciences AG Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 76. Biocrates Life Sciences AG Recent Developments
  • Table 77. Shimadzu Corporation Company Details
  • Table 78. Shimadzu Corporation Business Overview
  • Table 79. Shimadzu Corporation Metabolomics Product
  • Table 80. Shimadzu Corporation Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 81. Shimadzu Corporation Recent Developments
  • Table 82. Waters Corporation Company Details
  • Table 83. Waters Corporation Business Overview
  • Table 84. Waters Corporation Metabolomics Product
  • Table 85. Waters Corporation Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 86. Waters Corporation Recent Developments
  • Table 87. Human Metabolome Technologies, Inc. Company Details
  • Table 88. Human Metabolome Technologies, Inc. Business Overview
  • Table 89. Human Metabolome Technologies, Inc. Metabolomics Product
  • Table 90. Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 91. Human Metabolome Technologies, Inc. Recent Developments
  • Table 92. LECO Corporation Company Details
  • Table 93. LECO Corporation Business Overview
  • Table 94. LECO Corporation Metabolomics Product
  • Table 95. LECO Corporation Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 96. LECO Corporation Recent Developments
  • Table 97. Metabolon, Inc. Company Details
  • Table 98. Metabolon, Inc. Business Overview
  • Table 99. Metabolon, Inc. Metabolomics Product
  • Table 100. Metabolon, Inc. Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 101. Metabolon, Inc. Recent Developments
  • Table 102. Bio-Rad Laboratories, Inc. Company Details
  • Table 103. Bio-Rad Laboratories, Inc. Business Overview
  • Table 104. Bio-Rad Laboratories, Inc. Metabolomics Product
  • Table 105. Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 106. Bio-Rad Laboratories, Inc. Recent Developments
  • Table 107. Bruker Corporation Company Details
  • Table 108. Bruker Corporation Business Overview
  • Table 109. Bruker Corporation Metabolomics Product
  • Table 110. Bruker Corporation Revenue in Metabolomics Business (2017-2022) & (US$ Million)
  • Table 111. Bruker Corporation Recent Developments
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Metabolomics Market Share by Type: 2021 VS 2028
  • Figure 2. Separation Techniques Features
  • Figure 3. Detection Techniques Features
  • Figure 4. Others Features
  • Figure 5. Global Metabolomics Market Share by Application: 2021 VS 2028
  • Figure 6. Drug Assessment Case Studies
  • Figure 7. Biomarker Discovery Case Studies
  • Figure 8. Nutrigenomics Case Studies
  • Figure 9. Clinical toxicology Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. Metabolomics Report Years Considered
  • Figure 12. Global Metabolomics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Metabolomics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Metabolomics Market Share by Region: 2021 VS 2028
  • Figure 15. Global Metabolomics Market Share by Players in 2021
  • Figure 16. Global Top Metabolomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Metabolomics Revenue in 2021
  • Figure 18. North America Metabolomics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Metabolomics Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Metabolomics Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Metabolomics Market Size Share by Country (2017-2028)
  • Figure 22. United States Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Metabolomics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Metabolomics Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Metabolomics Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Metabolomics Market Size Share by Country (2017-2028)
  • Figure 28. Germany Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Metabolomics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Metabolomics Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Metabolomics Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Metabolomics Market Size Share by Region (2017-2028)
  • Figure 38. China Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Latin America Metabolomics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Metabolomics Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Metabolomics Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Metabolomics Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Metabolomics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Metabolomics Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Metabolomics Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Metabolomics Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Metabolomics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 58. Agilent Technologies, Inc. Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 59. Biocrates Life Sciences AG Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 60. Shimadzu Corporation Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 61. Waters Corporation Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 62. Human Metabolome Technologies, Inc. Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 63. LECO Corporation Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 64. Metabolon, Inc. Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 65. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 66. Bruker Corporation Revenue Growth Rate in Metabolomics Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed